These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 6389185)

  • 1. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
    Weinbauer GF; Surmann FJ; Akhtar FB; Shah GV; Vickery BH; Nieschlag E
    Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of spermatogenesis in a nonhuman primate (Macaca fascicularis) by concomitant gonadotropin-releasing hormone antagonist and testosterone treatment.
    Weinbauer GF; Surmann FJ; Nieschlag E
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):138-46. PubMed ID: 3544633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic effects of a gonadotrophin-releasing hormone antagonist on pituitary and testicular function in monkeys.
    Bint Akhtar F; Weinbauer GF; Nieschlag E
    J Endocrinol; 1985 Mar; 104(3):345-54. PubMed ID: 3882872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a gonadotropin-releasing hormone agonist on luteinizing hormone and testosterone secretion and testicular histology in male rhesus monkeys.
    Mann DR; Smith MM; Gould KG; Collins DC
    Fertil Steril; 1985 Jan; 43(1):115-21. PubMed ID: 3880709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained inhibition of sperm production and inhibin secretion induced by a gonadotrophin-releasing hormone antagonist and delayed testosterone substitution in non-human primates (Macaca fascicularis).
    Weinbauer GF; Khurshid S; Fingscheidt U; Nieschlag E
    J Endocrinol; 1989 Nov; 123(2):303-10. PubMed ID: 2691619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.
    Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA
    J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone prevents complete suppression of spermatogenesis in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
    Weinbauer GF; Göckeler E; Nieschlag E
    J Clin Endocrinol Metab; 1988 Aug; 67(2):284-90. PubMed ID: 3292557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size, and serum inhibin levels in the gonadotropin-releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis).
    Weinbauer GF; Behre HM; Fingscheidt U; Nieschlag E
    Endocrinology; 1991 Oct; 129(4):1831-9. PubMed ID: 1915071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of the potential utility of LHRH agonists and antagonists for fertility control.
    Vickery BH
    J Steroid Biochem; 1985 Nov; 23(5B):779-91. PubMed ID: 3001420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developments in the control of testicular function.
    Swerdloff RS; Wang C; Bhasin S
    Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibility of long-term effects of GnRH agonist administration on testicular histology and sperm production in the nonhuman primate.
    Weinbauer GF; Respondek M; Themann H; Nieschlag E
    J Androl; 1987; 8(5):319-29. PubMed ID: 2959641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous infusion of a low dose of GnRH antagonist on serum LH and testosterone concentrations, spermatogenesis and semen quality in the rhesus monkey (Macaca mulatta).
    Mann DR; Collins DC; Smith MM; Gould KG
    J Reprod Fertil; 1987 Nov; 81(2):485-93. PubMed ID: 3323497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of simultaneous gonadotropin-releasing hormone agonist and testosterone treatment on spermatogenesis and potential fertilizing capacity in male monkeys.
    Mann DR; Gould KG; Smith MM; Duffey T; Collins DC
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1215-24. PubMed ID: 3316265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone maintains pituitary and serum FSH and spermatogenesis in gonadotrophin-releasing hormone antagonist-suppressed rats.
    Rea MA; Marshall GR; Weinbauer GF; Nieschlag E
    J Endocrinol; 1986 Jan; 108(1):101-7. PubMed ID: 3003219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.